Company Filing History:
Years Active: 2013
Title: Fabrice Godfroid: Innovator in Vaccination Technology
Introduction
Fabrice Godfroid is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of vaccination, particularly in the development of pertussis antigens. His work has implications for both diagnostic and therapeutic applications in immunology.
Latest Patents
Fabrice holds a patent for "Pertussis antigens and use thereof in vaccination." This invention provides BASB232 polypeptides and polynucleotides encoding these polypeptides, along with methods for producing them through recombinant techniques. The patent also outlines diagnostic, prophylactic, and therapeutic uses of these antigens. Furthermore, it includes immunogenic compositions that comprise a variety of antigens selected from at least two different categories, each serving different functions. Examples of these categories include autotransporter proteins, iron acquisition proteins, lipoproteins, adhesins, and toxins/invasins. He has 1 patent to his name.
Career Highlights
Fabrice Godfroid has been associated with GlaxoSmithKline Biologicals SA, where he has contributed to innovative research in vaccine development. His expertise in immunology and biotechnology has positioned him as a key figure in the advancement of vaccination technologies.
Collaborations
Fabrice has worked alongside notable colleagues such as Cindy Castado and Philippe Denoel. Their collaborative efforts have further enhanced the research and development of effective vaccination strategies.
Conclusion
Fabrice Godfroid's contributions to the field of vaccination through his innovative patent work exemplify the importance of research in public health. His ongoing efforts in collaboration with industry leaders continue to pave the way for advancements in immunology.